Detalhe da pesquisa
1.
Carboplatin plus paclitaxel once a week versus every 3 weeks in patients with advanced ovarian cancer (MITO-7): a randomised, multicentre, open-label, phase 3 trial.
Lancet Oncol
; 15(4): 396-405, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24582486
2.
The Promher Study: An Observational Italian Study on Adjuvant Therapy for HER2-Positive, pT1a-b pN0 Breast Cancer.
PLoS One
; 10(9): e0136731, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26340098
3.
Correction: The Promher Study: An Observational Italian Study on Adjuvant Therapy for HER2-Positive, pT1a-b pN0 Breast Cancer.
PLoS One
; 10(9): e0139650, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26406908